Press Releases

Sep 13, 2022

ProBioGen Receives Employer of the Future and Top Service Awards

read more ProBioGen Receives Employer of the Future and Top Service Awards

download PDF

Sep 07, 2022

ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine

read more ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine

download PDF

Aug 17, 2022

ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing

read more ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing

download PDF

Jul 12, 2022

ProBioGen Teams Up with Granite Bio for Cell Line Development and GMP Manufacturing Services

read more ProBioGen Teams Up with Granite Bio for Cell Line Development and GMP Manufacturing Services

download PDF

Jun 14, 2022

ValenzaBio Engages ProBioGen For a Second Service Project

read more ValenzaBio Engages ProBioGen For a Second Service Project

download PDF

Jun 02, 2022

ProBioGen Grows by 50 Percent in Last Two Years

read more ProBioGen Grows by 50 Percent in Last Two Years

download PDF

Mar 07, 2022

Lutz Hilbrich Appointed as Senator to the Senate of Economy Europe

read more Lutz Hilbrich Appointed as Senator to the Senate of Economy Europe

download PDF

Feb 11, 2022

ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology

read more ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology

download PDF

Jan 11, 2022

ProBioGen announces Innovent as a new Partner signing License of GlymaxX® Technology

read more ProBioGen announces Innovent as a new Partner signing License of GlymaxX® Technology

download PDF

Jan 06, 2022

Imvaq Therapeutics signs a Service and Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

read more Imvaq Therapeutics signs a Service and Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

download PDF

Page 1 of 10

1
2
3
4
5
6
7
Next
Last »

ProBioGen News

Join our news and always be up-to-date.

Sign up